Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMED7 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | NINL | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZNF627 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | FGL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | KANSL1L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | C3orf22 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | LGALS14 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | RNF207 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | RNPS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZNF136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |